Register Your Interest
Register your interest in the course. When we schedule dates, we will be in touch.
Understand the major components of portfolio management to capitalise on strategic opportunities. – Click Here to Download the Agenda
Register your interest in the course. When we schedule dates, we will be in touch.
Learn more about the course by toggling through the tabs below. Scroll down to view the agenda, trainer info and who should attend.
In the dynamic and highly competitive biopharmaceutical industry, effective portfolio management is crucial for maintaining a robust pipeline, mitigating risks, and ensuring long-term success. It is critical for management and business development professionals to have the skills to critically appraise their pipelines and evaluate opportunities with ease.
This course aims to provide biopharma professionals with the knowledge and skills needed to optimise their organisation’s R&D and commercial portfolios. By the end of the course, participants will gain a deep understanding of managing and optimising a biopharmaceutical portfolio. They will be empowered to make strategic decisions that improve pipeline health, minimise risks, take advantage of opportunities for growth, and enhance the overall visibility of their organisation’s activities, ultimately leading to a more robust and successful portfolio.
Find out when this course is running so you can plan your training. Scroll down to view the full agenda.
2-Day Live Online Training
Register at the top of the page.
If you want to train a small group, we offer a group discount between 5% and 50% depending on the course and number of attendees.
For a quote, complete our contact form by following the link. Get in touch.
We also design and deliver fully customised team training focused on your products, processes, technologies and challenges. This is ideal for specific training requirements or larger groups. Please get in touch with us for more information.
For more information, complete our contact form by following the link. Get in touch.
Learn more about the course by toggling through the tabs below (trainer, agenda, who should attend?)
Course Information
Introduction to Portfolio Management in Biopharma
Pipeline Health and Management
Risk Management in Portfolio Governance
Identifying and Managing Inflection Points
Strategic Partnering and Collaborations
Leveraging Differentiation and Competitive Intelligence
Enhancing External Visibility
Case Studies and Best Practices
Gareth is an experienced biopharmaceutical R&D professional, drug hunter and global project lead with 10+ years of leadership in project/program management, portfolio governance and scientific strategy. He has a successful record of progressing complex, multi-million-dollar drug development programs through internal and external initiatives. He has furthered his practical experience in both Europe and the US, in clinical, pharmaceutical, VC and academic environments facilitating the preclinical -> clinical transition of novel medicinal products. Relevant former roles and institutions include Principal Investigator/Lecturer (Harvard Medical School & Boston Children’s Hospital), Fellow and Project Lead (Vertex Pharmaceuticals), Global Project Lead (Boehringer-Ingelheim) and Asset and Scientific Evolution Lead (invoX Pharma).
In his current role(s), he leads a dynamic cross-functional global team that pushes scientific and drug development boundaries, developing novel medicinal products and drug-device combinations (modality and indication agnostic), to meet unmet patient needs worldwide. He has a wealth of experience in establishing agile governance frameworks to oversee a diverse clinical and preclinical portfolio. Notably, he has extensive experience in translational biomarker strategies, indication expansions (repurposing), and effective tech-transfer for up-scale bioprocessing of biologics.
Overseeing a global team, Gareth has a proven track record in increasing pipeline visibility and executing external collaborations. He has bridged the gap between preclinical -> clinical, implementing novel ‘first-4-patient’ initiatives, such as 5’R research frameworks, relevant clinical biomarker strategies and optimising human dose prediction models to enhance the probability of success of medicinal products.
This course is designed for biopharmaceutical professionals working in small biotech and large biopharma companies, specialising in portfolio management, project management, R&D strategy, governance, business development, and strategic partnerships.
It is also beneficial for senior executives who want to improve their understanding of portfolio governance and strategic decision-making.
Discount has been applied to the price above. VAT, if applicable, will be added.
You can view the agenda below or if you would like to receive a pdf version with all the course information, please complete the form below.
Reviews
There are no reviews yet.